Scientists at the Institute of Cancer Research (ICR) in the UK have found that inhibition of the cyclin G associated kinase (GAK) protein has the potential to allow treatment of different types of cancer.
Scientists at the Institute of Cancer Research (ICR) in the UK have found that inhibition of the cyclin G associated kinase (GAK) protein has the potential to allow treatment of different types of cancer.